Literature DB >> 12368367

Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET.

Corneline J Hoekstra1, Otto S Hoekstra, Sigrid G Stroobants, Johan Vansteenkiste, Johan Nuyts, Egbert F Smit, Maarten Boers, Jos W R Twisk, Adriaan A Lammertsma.   

Abstract

UNLABELLED: PET using 18F-FDG is a promising technique to monitor response in oncology. Unfortunately, a multitude of analytic methods is in use. To date, it is not clear whether simplified methods could replace complex quantitative methods in routine clinical practice. The aim of this study was to select those methods that would qualify for further assessment in a future prospective response-monitoring study by comparing results with patient outcome.
METHODS: Dynamic 18F-FDG PET scans were obtained on 2 groups of patients. First, 10 patients with advanced non-small cell lung cancer (NSCLC) were scanned on consecutive days before treatment to assess test-retest variability. Second, 30 scans were obtained on 19 patients with locally advanced NSCLC as part of an ongoing response-monitoring study. These scans were analyzed by 2 observers to assess observer variability. In addition, these studies were used to compare various methods with the gold standard, full kinetic analysis (nonlinear regression [NLR]).
RESULTS: Using an image-derived input function, NLR showed excellent test-retest and observer agreement confirming that it could be used as a gold standard method. From a total of 34 analytic methods, 10 showed good correlation with NLR. Taking into account the degree of complexity of the methods, 4 remain for further evaluation.
CONCLUSION: The optimal method for analysis of 18F-FDG PET data was determined for several levels of complexity. Four methods need to be evaluated further to determine the optimal trade-off between simplicity and accuracy for routine clinical practice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368367

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  40 in total

Review 1.  Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations.

Authors:  Nanda C Krak; Otto S Hoekstra; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-22       Impact factor: 9.236

2.  Metrology Standards for Quantitative Imaging Biomarkers.

Authors:  Daniel C Sullivan; Nancy A Obuchowski; Larry G Kessler; David L Raunig; Constantine Gatsonis; Erich P Huang; Marina Kondratovich; Lisa M McShane; Anthony P Reeves; Daniel P Barboriak; Alexander R Guimaraes; Richard L Wahl
Journal:  Radiology       Date:  2015-08-12       Impact factor: 11.105

3.  Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial.

Authors:  Nanda C Krak; R Boellaard; Otto S Hoekstra; Jos W R Twisk; Corneline J Hoekstra; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-10-15       Impact factor: 9.236

Review 4.  How should we analyse FDG PET studies for monitoring tumour response?

Authors:  Adriaan A Lammertsma; Corneline J Hoekstra; Giuseppe Giaccone; Otto S Hoekstra
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07       Impact factor: 9.236

5.  Local motion correction for lung tumours in PET/CT--first results.

Authors:  Ralph A Bundschuh; Axel Martínez-Möller; Markus Essler; Stephan G Nekolla; Sibylle I Ziegler; Markus Schwaiger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-06       Impact factor: 9.236

6.  Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.

Authors:  Wolfgang A Weber; Constantine A Gatsonis; P David Mozley; Lucy G Hanna; Anthony F Shields; Denise R Aberle; Ramaswamy Govindan; Drew A Torigian; Joel S Karp; Jian Q Michael Yu; Rathan M Subramaniam; Robert A Halvorsen; Barry A Siegel
Journal:  J Nucl Med       Date:  2015-04-23       Impact factor: 10.057

7.  PET imaging in pediatric neuroradiology: current and future applications.

Authors:  Sunhee Kim; Noriko Salamon; Hollie A Jackson; Stefan Blüml; Ashok Panigrahy
Journal:  Pediatr Radiol       Date:  2009-11-24

8.  Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods.

Authors:  Nanda C Krak; Jacobus J M van der Hoeven; Otto S Hoekstra; Jos W R Twisk; Elsken van der Wall; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-15       Impact factor: 9.236

9.  Repeatability of gallium-68 DOTATOC positron emission tomographic imaging in neuroendocrine tumors.

Authors:  Yusuf Menda; Laura L Boles Ponto; Michael K Schultz; Gideon K D Zamba; G Leonard Watkins; David L Bushnell; Mark T Madsen; John J Sunderland; Michael M Graham; Thomas M O'Dorisio; M Sue O'Dorisio
Journal:  Pancreas       Date:  2013-08       Impact factor: 3.327

10.  Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET.

Authors:  A Stahl; K Ott; M Schwaiger; W A Weber
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-15       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.